融信中國(03301.HK)核數師辭任 延遲刊發去年度業績
融信中國(03301.HK)公布,羅兵咸永道已辭任公司核數師,自上周五(18日)起生效。
羅兵咸永道在其辭任函中指出,針對銀行回覆的詢證函中所述集團的個別銀行存款抵押,集團管理層須作出進一步澄清;所要求資料的提供及銀行確認函的收發工作落後於計劃;及鑑於上述原因,羅兵咸永道無法於協定時間表內就集團截至去年12月底止年度的年度業績完成全部審核工作。
公司指出,由於中國近期爆發疫情,集團的財務匯報及審核程序受到不利影響,且集團與羅兵咸永道未能就集團去年度業績審核工作的審核費用總額協商並達成一致,亦未能就完成有關審核工作制定雙方同意的時間表。
此外,公司無法於3月底前刊發去年度業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.